Back to search
FDAFDA · Food and drugs·Recall number D-0328-2023

BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-340-01; NDC Blister Pack: 60687-340-11

Published February 22, 2023 · Recall initiated: December 27, 2022

Summary

FDA records drug Class II recall D-0328-2023, published February 22, 2023 and initiated December 27, 2022. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 1,416 cartons; Lot: Lot #: 1003837, Exp. Date 01/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if BUPROPION HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUPROPION HYDROCHLORIDE
Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide within the USA
Lot
Lot #: 1003837, Exp. Date 01/31/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-340-01; NDC Blister Pack: 60687-340-11 recalled?

Yes. FDA published recall D-0328-2023 on February 22, 2023. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPROPION HYDROCHLORIDE.